Abstract Receptor mediated calcium entry (RMCE) is a now recognised mechanism by which the influx of Ca 2+ into cells can occur. Agents which antagonise or block this mechanism are expected to possess anti-platelet aggregation and anti-inflammatory activities. The first series of RMCE blockers based upon the lead compound SC 38249, has been prepared. Their synthesis, activity against ADP evoked Ca 2+ signals in human ...
